{
    "id": "b7e57ea4-d985-4167-8c2d-716cf3c60114",
    "indications": "Gabapentin Capsules are indicated for: \n                  \n                     Management      of postherpetic neuralgia in adults\n                     Adjunctive      therapy in the treatment of partial onset seizures, with and without      secondary generalization, in adults and pediatric patients 3 years and      older with epilepsy",
    "contraindications": "Postherpetic      Neuralgia ( 2.1 ) Dose      can be titrated up as needed to a      dose of 1,800 mg/day Day      1: Single 300 mg dose Day      2: 600 mg/day (i.e., 300 mg two times      a day) Day      3: 900 mg/day (i.e., 300 mg three      times a day) Epilepsy      with Partial Onset Seizures ( 2.2 ) Patients      12 years of age and older:      starting dose is 300 mg three times daily;      may be titrated up to 600 mg      three times daily Patients      3 to 11 years of age: starting      dose range is 10 to 15 mg/kg/day,      given in three divided doses;      recommended dose in patients 3 to 4      years of age is 40 mg/kg/day, given in      three divided doses; the      recommended dose in patients 5 to 11 years of age      is 25 to 35 mg/kg/day,      given in three divided doses. The recommended dose      is reached by      upward titration over a period of approximately 3 days Dose      should be adjusted in patients with      reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions": "Gabapentin Capsules, USP are available containing 100 mg, 300 mg or 400 mg of gabapentin, USP, supplied as follows:\n                  100 mg capsules:\n                  Size '3' Hard gelatin capsules with white opaque cap and white opaque body, imprinted \"100 mg\" in blue ink on cap and \"236\" in blue ink on body, filled with white to off-white powder.\n                  Capsules are supplied in bottles of:\n                  Bottles of 30 Capsules with child-resistant closure                NDC 16571-867-03\n                  Bottles of 100 Capsules with child-resistant closure              NDC 16571-867-01\n                  Bottles of 500 Capsules                                                          NDC 16571-867-50\n                  Bottles of 1,000 Capsules                                                       NDC 16571-867-10\n                      \n                  300 mg capsules:\n                  Size '1' Hard gelatin capsules with yellow opaque cap and yellow opaque body, imprinted \"300 mg\" in blue ink on cap and \"235\" in blue ink on body, filled with white to off-white powder.\n                  Capsules are supplied in bottles of:\n                  Bottles of 30 Capsules with child-resistant closure                NDC 16571-868-03\n                  Bottles of 100 Capsules with child-resistant closure              NDC 16571-868-01\n                  Bottles of 500 Capsules                                                          NDC 16571-868-50\n                  Bottles of 1,000 Capsules                                                       NDC 16571-868-10\n                  400 mg capsules:\n                  Size '0' Hard gelatin capsules with orange opaque cap and orange opaque body, imprinted \"400 mg\" in blue ink on cap and \"234\" in blue ink on body, filled with white to off-white powder.\n                  Capsules are supplied in bottles of:\n                  Bottles of 30 Capsules with child-resistant closure                NDC 16571-869-03\n                  Bottles of 100 Capsules with child-resistant closure              NDC 16571-869-01\n                  Bottles of 500 Capsules                                                          NDC 16571-869-50\n                  Bottles of 1,000 Capsules                                                       NDC 16571-869-10\n                  \n                     Storage\n                  \n                  Store at 20°C to 25°C (68°F to 77°F); [see USP Controlled Room Temperature].",
    "adverseReactions": "Gabapentin capsules are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        }
    ],
    "organization": "Rising Pharma Holdings, Inc.",
    "name": "gabapentin",
    "effectiveTime": "20250125"
}